CASP1 single-nucleotide polymorphisms were associated with changes in NF-κB signaling and development of other non-Hodgkin lymphomas, including diffuse-large B cell lymphomas and small lymphocytic lymphoma/chronic lymphocytic leukemia (59). This evidence concerns the gene CASP1 and diffuse large B-cell lymphoma.